Study on Immunogenicity, Reactogenicity and Safety of the VAC Δ6 Vaccine in Volunteers Aged 18-60 Years
Conditions: Smallpox; Monkeypox; Cowpox; Vaccinia Virus Infection Interventions: Biological: VAC∆6 vaccine (10⁷ PFU); Biological: VAC∆6 vaccine (10⁶ PFU); Biological: Live Smallpox Vaccine; Other: Placebo (Sodium chloride bufus, 0.9%) Sponsor: Federal Budgetary Research Institution State Research Center of Virology and Biotechnology " Vector " Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Monkeypox | Research | Smallpox | Smallpox Vaccine | Study | Vaccines | Virology